Since tumour suppressor gene PTEN is a direct regulatory target of GRHL3, GRHL3 has a positive regulatory effect on it in vivo and can regulate the occurrence and development of tumours by activating the PI3K/Akt pathway. The gene discussed is PTEN; the disease is neoplasm.